A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)
Public ClinicalTrials.gov record NCT03571256. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Well-Controlled, Fixed-Dose Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tics Associated With Tourette Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Standard placebo-controlled, double-blind study design (TEV-50717 \[low dose and high dose\] vs. placebo in a 1:1:1 ratio) was chosen to determine whether study drug treatment results in a statistically significant effect on the tics in participants with TS.
Study identification
- NCT ID
- NCT03571256
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 158 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 16 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2018 (Actual)
- Primary completion
- Dec 9, 2019 (Actual)
- Completion
- Dec 9, 2019 (Actual)
- Last update posted
- Nov 9, 2021
2018 – 2019
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 060-0160 | Gainesville | Florida | 32608 | — |
| Teva Investigational Site 060-0166 | Gulf Breeze | Florida | 32561-4458 | — |
| Teva Investigational Site 060-0161 | Miami | Florida | 33136-2107 | — |
| Teva Investigational Site 060-0151 | Orlando | Florida | 32801 | — |
| Teva Investigational Site 060-0153 | Orlando | Florida | 32819 | — |
| Teva Investigational Site 060-0168 | Atlanta | Georgia | 30329 | — |
| Teva Investigational Site 060-0155 | Chicago | Illinois | 60612 | — |
| Teva Investigational Site 060-0164 | Chicago | Illinois | 60634 | — |
| Teva Investigational Site 060-0152 | Indianapolis | Indiana | 46256 | — |
| Teva Investigational Site 060-0158 | Louisville | Kentucky | 40202 | — |
| Teva Investigational Site 060-0167 | Rockville | Maryland | 20852-4219 | — |
| Teva Investigational Site 060-0165 | Ann Arbor | Michigan | 48105 | — |
| Teva Investigational Site 060-0170 | Bridgeton | Missouri | 63044 | — |
| Teva Investigational Site 060-0154 | New York | New York | 10036 | — |
| Teva Investigational Site 060-0169 | Charleston | South Carolina | 29414-5834 | — |
| Teva Investigational Site 060-0157 | Memphis | Tennessee | 38157 | — |
| Teva Investigational Site 060-0156 | Nashville | Tennessee | 37232-2551 | — |
| Teva Investigational Site 060-0163 | Fort Worth | Texas | 76104 | — |
| Teva Investigational Site 060-0162 | Everett | Washington | 98201-4077 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03571256, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03571256 live on ClinicalTrials.gov.